NL9002366A - Nieuwe isoindoolderivaten en zouten daarvan, werkwijze voor de bereiding ervan en antitumorpreparaten die deze derivaten bevatten. - Google Patents

Nieuwe isoindoolderivaten en zouten daarvan, werkwijze voor de bereiding ervan en antitumorpreparaten die deze derivaten bevatten. Download PDF

Info

Publication number
NL9002366A
NL9002366A NL9002366A NL9002366A NL9002366A NL 9002366 A NL9002366 A NL 9002366A NL 9002366 A NL9002366 A NL 9002366A NL 9002366 A NL9002366 A NL 9002366A NL 9002366 A NL9002366 A NL 9002366A
Authority
NL
Netherlands
Prior art keywords
group
compound
general formula
unsubstituted
formula
Prior art date
Application number
NL9002366A
Other languages
English (en)
Dutch (nl)
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2-288069A external-priority patent/JP3027599B2/ja
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NL9002366A publication Critical patent/NL9002366A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL9002366A 1989-11-01 1990-10-31 Nieuwe isoindoolderivaten en zouten daarvan, werkwijze voor de bereiding ervan en antitumorpreparaten die deze derivaten bevatten. NL9002366A (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28554889 1989-11-01
JP20544390 1990-08-02
JP2-288069A JP3027599B2 (ja) 1990-08-02 1990-10-25 新規なイソインドール誘導体およびその塩

Publications (1)

Publication Number Publication Date
NL9002366A true NL9002366A (nl) 1991-06-03

Family

ID=27328497

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9002366A NL9002366A (nl) 1989-11-01 1990-10-31 Nieuwe isoindoolderivaten en zouten daarvan, werkwijze voor de bereiding ervan en antitumorpreparaten die deze derivaten bevatten.

Country Status (11)

Country Link
US (1) US5166204A (de)
BE (1) BE1004069A3 (de)
CA (1) CA2028960C (de)
CH (1) CH682151A5 (de)
DE (1) DE4034687C2 (de)
DK (1) DK261890A (de)
FR (1) FR2655345B1 (de)
GB (1) GB2239013B (de)
IT (1) IT1242004B (de)
NL (1) NL9002366A (de)
SE (1) SE509700C2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215361D0 (en) * 1992-07-20 1992-09-02 Wellcome Found Heterocyclic compounds
ES2123873T3 (es) * 1994-08-04 1999-01-16 Hoffmann La Roche Pirrolocarbazol.
AU4889496A (en) * 1995-03-09 1996-10-02 Kyowa Hakko Kogyo Co. Ltd. Pyrrolocarbazole derivatives
FR2751655B1 (fr) * 1996-07-26 1998-08-28 Adir Nouveaux derives de bis-imides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE19744257B4 (de) * 1997-10-07 2004-04-15 Zentaris Gmbh Beta-Carboline und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen
US20060276497A1 (en) * 2000-05-09 2006-12-07 Cephalon, Inc. Novel multicyclic compounds and the use thereof
US7122679B2 (en) * 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
EP1464645A1 (de) * 2001-12-18 2004-10-06 Kyowa Hakko Kogyo Co., Ltd. Indolderivat
CA2483496A1 (en) * 2002-04-26 2003-11-06 Warner-Lambert Company Llc Inhibitors of checkpoint kinases (wee1 and chk1)
CN100400529C (zh) * 2003-10-08 2008-07-09 中国科学院化学研究所 含氟芳香族有机四酸二酐及制备方法和用途
JP4857452B2 (ja) 2004-03-15 2012-01-18 ピーティーシー セラピューティクス,インコーポレーテッド 血管新生の抑制に有用なカルボリン誘導体
US7767689B2 (en) * 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
US8076352B2 (en) * 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
US8940896B2 (en) * 2004-03-15 2015-01-27 Ptc Therapeutics, Inc. Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis
US8076353B2 (en) * 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
CN101102765A (zh) * 2004-11-23 2008-01-09 Ptc医疗公司 通过翻译控制抑制vegf产生的活性物质四氢咔唑
US8946444B2 (en) * 2004-11-23 2015-02-03 Ptc Therapeutics, Inc. Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control
CN110464722B (zh) * 2019-06-06 2023-05-23 暨南大学 一类小分子化合物或其药学上可接受的盐在制备抗肿瘤转移药物中的应用
CN115594681B (zh) * 2022-10-21 2024-06-18 广州六顺生物科技有限公司 一种异吲哚啉-1,3-二酮衍生物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3752123T2 (de) * 1987-03-09 1998-05-14 Kyowa Hakko Kogyo Kk Derivate des physiologisch aktiven mittels k-252
DE3833008A1 (de) * 1988-09-29 1990-04-05 Goedecke Ag Pyrrolocarbozol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel

Also Published As

Publication number Publication date
US5166204A (en) 1992-11-24
DE4034687C2 (de) 1999-12-02
CH682151A5 (de) 1993-07-30
DK261890D0 (da) 1990-10-31
DE4034687A1 (de) 1991-05-02
BE1004069A3 (fr) 1992-09-15
SE509700C2 (sv) 1999-02-22
IT9048430A1 (it) 1992-05-01
IT1242004B (it) 1994-02-02
GB2239013A (en) 1991-06-19
GB2239013B (en) 1993-06-02
IT9048430A0 (it) 1990-10-31
FR2655345A1 (de) 1991-06-07
SE9003476L (sv) 1992-05-01
DK261890A (da) 1991-05-02
CA2028960C (en) 1999-01-19
SE9003476D0 (sv) 1990-10-31
FR2655345B1 (de) 1993-02-26
GB9023568D0 (en) 1990-12-12
CA2028960A1 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
NL9002366A (nl) Nieuwe isoindoolderivaten en zouten daarvan, werkwijze voor de bereiding ervan en antitumorpreparaten die deze derivaten bevatten.
KR100256707B1 (ko) 데아자푸린 유도체; 새로운 부류의 crf1 특이 리간드
US6610684B2 (en) Fused azepinone cyclin dependent kinase inhibitors
NZ511015A (en) 1, 6-Dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one derivatives useful for treating impotence
CZ20003960A3 (cs) Deriváty indolu a jejich pouľití pro léčení maligních a jiných chorob vyvolaných patologickou proliferací buněk
JP2001504109A (ja) ベンゾ複素環ジスタマイシン誘導体、それらを製造する方法および抗腫瘍および抗ウイルス剤としてのそれらの用途
WO2019158025A1 (zh) 一种三氮唑并嘧啶衍生化合物、包含其的药物组合物及其用途
EA004373B1 (ru) 1-АМИНОТРИАЗОЛО[4,3-a]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ IV
EP0491218A1 (de) Benzodiazepinone
WO2005111040A1 (en) Pyrrolobenzimidazolones and their use as antiproliferative agents
JP2022517723A (ja) Cdk阻害剤としての大環状化合物、その製造方法及びその医薬品における応用
HUT76787A (en) Pyrrole ring containing tetracyclic compounds, process for their preparation and pharmaceutical compositions containing them
US20220169609A1 (en) Indole-ynone mediated benzoannulation process for the preparation of carbazoles, carbazomycin a, calothrixin b and staurosporinone
KATO et al. New 5-HT3 (Serotonin-3) receptor antagonists. II. Synthesis and structure-activity relationships of pyrimido [1, 6-α] indoles
CN111269215B (zh) 含氮杂环有机化合物及其制备方法和应用
KR930001407B1 (ko) 신규한 이소인돌 유도체 및 그의 염, 이의 제조방법 및 이를 포함하는 종양치료제
CZ20022492A3 (cs) Substituované pyrroly
JP3027599B2 (ja) 新規なイソインドール誘導体およびその塩
US6300340B1 (en) Bisimide compounds
EP1266887B1 (de) Indenoindolin Derivate, Verfahren zur Herstellung dieser Derivate und diese enthaltende pharmazeutische Präparate
JP3025536B2 (ja) 新規なカルバゾール誘導体およびその塩
JP3178880B2 (ja) 新規なインドール誘導体およびその塩
JPS59141580A (ja) インド−ル誘導体
WO2022199045A1 (zh) 双环杂环fgfr4抑制剂,包含其的药物组合物和制剂,及其应用
AU2022240688A1 (en) Furan fused ring-substituted glutarimide compound

Legal Events

Date Code Title Description
AK Correction of former applications already laid open

Free format text: IN PAT.BUL.11/91,PAGE 1387:SHOULD BE DELETED

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed